TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An announcement from Pharmaust Limited ( (AU:NUZ) ) is now available.
Neurizon Therapeutics Limited, a company focused on neurodegenerative diseases, presented at their AGM with insights into their future strategies and expectations. The presentation highlighted the company’s intentions and plans, though it noted that these are subject to risks and uncertainties, which may impact the actual outcomes. Stakeholders are advised to consider these factors when evaluating the company’s future performance.
The most recent analyst rating on (AU:NUZ) stock is a Buy with a A$0.56 price target. To see the full list of analyst forecasts on Pharmaust Limited stock, see the AU:NUZ Stock Forecast page.
More about Pharmaust Limited
Average Trading Volume: 778,681
Technical Sentiment Signal: Sell
Current Market Cap: A$58.82M
For a thorough assessment of NUZ stock, go to TipRanks’ Stock Analysis page.